discount coupons for downloading, and they do not provide physical e-commerce purchases. >
In the next 3 days, most of Guangxi will be dominated by cloudy weather to see how to get rid of moisture
Time of Update: 2021-05-02
After 9 days of intermittent rainfall, on June 12, except for some areas of southern Guangxi where there were still showers or thunderstorms, and local heavy rains, the weather in most parts of Guangxi improved.
Izcargo, a biological product that crosses the blood-brain barrier, was approved for the first time on the market
Time of Update: 2021-05-02
A few days ago, JCR Pharmaceuticals announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan has approved Izcargo (pabinafusp alfa) for the treatment of mucopolysaccharidosis type II (MPS II, also known as Hunter syndrome).
Latest research | Aging causes muscle loss
Time of Update: 2021-05-02
A recent study published in "Stem Cell Research & Therapy" found that using a small artificial molecule called givinostat to induce stem cells to differentiate into muscle progenitor cells or muscle cells can promote muscle repair and regeneration.
Jack Ma Shame on Wall Street: Yesterday you were indifferent to me, but today I make you unable to climb high
Time of Update: 2021-05-02
" On September 8th, Jack Ma made such an opening remark at Alibaba's New York IPO (Initial Public Offering) roadshow.
How many people have received the new crown vaccine and have been
Time of Update: 2021-05-02
Data show that since December 14, 2020, as of April 13, 2021, more than 75 million people in the United States have completed the new crown vaccination program.
Acadi blockbuster dementia drug Nuplazid rejected by FDA
Time of Update: 2021-05-02
, claiming that not enough patients with dementia subtypes have shown effectiveness and did not raise safety issues.
>
And Acadia pointed out that they had
China Unicom joins hands with Baidu to push Internet financial products to seek O2O entry
Time of Update: 2021-05-02
If the trial is successful, more businesses will be developed on this basis to create an O2O portal] After China Telecom launched the financial wealth management product "Tianyibao", another major operator also started to take action.
Do you dare to challenge the six most dangerous self-driving routes in China
Time of Update: 2021-05-02
The editor is a
Nuocheng Jianhua Obutinib Obtained NMPA Approval to Start Phase II Clinical Study for Treatment of Multiple Sclerosis
Time of Update: 2021-05-02
According to the analysis data of Frost & Sullivan, the global MS market reached 23 billion U.
In 2020, the global antibody drug market will exceed $150 billion, and the five major target "cornucopia" will be released
Time of Update: 2021-05-02
>
In the past two months, following the disclosure of the financial reports of various pharmaceutical giants, the annual global
Microsoft's counterattack: Another physical store opens in the United States
Time of Update: 2021-05-02
Consumers can try out Microsoft products, experience Xbox games, play ithome.
The latest research on the two most common cancer-causing mutations found a new treatment strategy for the "king of cancer
Time of Update: 2021-05-02
, which leads to the disease at the advanced stage when it is diagnosed. Another important reason is that pancreatic cancer is highly resistant to most treatments. Therefore, it is urgent to develop innovative treatments
Nuocheng Jianhua's RTK inhibitor ICP-033 new drug research application was approved by the National Drug Administration
Time of Update: 2021-05-02
Nuocheng Jianhua announced today that the company's new multi-target receptor tyrosine kinase (RTK) inhibitor ICP-033 New Drug Research (IND) application has been accepted by the National Medical Products Administration (NMPA).
